Finds a study published on the web by the British Medical Journal.

Also after taking account of additional known risk factors for cognitive impairment, anticholinergic medicines remained the most highly significant predictor of the condition, say the authors. Provided the aim of identifying moderate cognitive impairment is the early treatment of dementia, people who have mild cognitive impairment due to anticholinergic drugs could possibly be in the absurd circumstance of receiving pro-cholinergic medicines to counteract the effects of anticholinergic agents, state the authors.Additionally, the Company is initiating a Stage 2 clinical study in immunocompromised pediatric and adult hematopoietic stem cell transplant individuals with AdV attacks. Data out of this open-label clinical study will be a critical element of our strategy to develop CMX001 as a broad-spectrum antiviral agent, stated Kenneth I. Moch, President and CEO of Chimerix. CMX001 can be exhibiting a favorable tolerability indicators and profile of powerful antiviral activity across our scientific studies, including the a lot more than 130 Crisis INDs requested by leading investigators, stated Wendy Painter, M.D., M.P.H., Chief Medical Officer of Chimerix.

Other entries from category "reports":

Random entries